ABOUT
BiolMed is an innovation driven biomedical products company. We develop and manufacture bioabsorbable implants for soft and hard tissue repair and also non-adherent wound dressings.
ABOUT
News
BiolMed receives the DBT-BIRAC-BIPP grant funding
Feb 2018: Biotechnology Industry Research Assistance Council (BIRAC) approved the BIPP funding for the flagship product of BiolMed - Serioss. The funding approved is to the tune of 1.5 Cr. The funding will accelerate the product development path for Serioss.
BIRAC awards SBIRI grant to BiolMed Innovations
Feb 2017: Biotechnology Industry Research Assistance Council (BIRAC) approved the funding for SBIRI for the second product that the company is developing. The company was approved funding of ₹ 24.96 Lakhs. The funding will support the development of a composite matrix for soft tissue reconstruction.
BiolMed wins the prestigious Biotechnology Ignition Grant from DBT-BIRAC
June 2015: Biotechnology Industry Research Assistance Council (BIRAC) approved the funding for BiolMed Innovations in the fourth round for the Biotechnology Ignition Grant (BIG). The company was approved funding of ₹ 49.26 Lakhs. The funding will support the initial set up for the first product development for BiolMed.